{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T10:27:53Z","timestamp":1775816873170,"version":"3.50.1"},"reference-count":5,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","jaad.org","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.jaad.2020.11.044","type":"journal-article","created":{"date-parts":[[2020,11,27]],"date-time":"2020-11-27T16:10:20Z","timestamp":1606493420000},"page":"269-271","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Spironolactone in the treatment of adolescent acne: A retrospective review"],"prefix":"10.1016","volume":"85","author":[{"given":"Hannah S.","family":"Berman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carol E.","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcia","family":"Hogeling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jaad.2020.11.044_bib1","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.jaad.2017.04.016","article-title":"Trends in prescribing behavior of systemic agents used in the treatment of acne\u00a0among dermatologists and nondermatologists: a retrospective analysis, 2004-2013","volume":"77","author":"Barbieri","year":"2017","journal-title":"J Am Acad Dermatol"},{"issue":"9","key":"10.1016\/j.jaad.2020.11.044_bib2","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1111\/jdv.16302","article-title":"Treatment of acne with spironolactone: a retrospective review of 395 adult patients at Mayo Clinic, 2007\u20132017","volume":"34","author":"Roberts","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"Suppl 1","key":"10.1016\/j.jaad.2020.11.044_bib3","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2165\/1153874-S0-000000000-00000","article-title":"Ethinylestradiol\/chlormadinone acetate dermatological benefits","volume":"12","author":"Guerra-Tapia","year":"2011","journal-title":"Am J Clin Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2020.11.044_bib4","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1159\/000018130","article-title":"Predictive factors for failure of isotretinoin treatment in acne patients: results from a cohort of 237 patients","volume":"198","author":"Lehucher-Ceyrac","year":"1999","journal-title":"Dermatology"},{"issue":"3","key":"10.1016\/j.jaad.2020.11.044_bib5","doi-asserted-by":"crossref","first-page":"e12873","DOI":"10.1111\/dth.12873","article-title":"Perceptions about oral isotretinoin treatment","volume":"32","author":"Tugrul Ayanoglu","year":"2019","journal-title":"Dermatol Ther"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962220330905?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962220330905?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,27]],"date-time":"2024-08-27T23:24:48Z","timestamp":1724801088000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962220330905"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":5,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["S0190962220330905"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2020.11.044","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Spironolactone in the treatment of adolescent acne: A retrospective review","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2020.11.044","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}